Nupam P Mahajan

10PUBLICATIONS
71CO-AUTHORS
Molecular targetsChemical and thermal processes in energy and combustionCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 30, 2026
ACK1 inhibition suppresses topoisomerase IIα, causing DNA damage accumulation and cellular senescence in RAS mutant lung cancer cells.

|Jul 04, 2024
SHP2 as a primordial epigenetic enzyme expunges histone H3 pTyr-54 to amend androgen receptor homeostasis.

Surbhi Chouhan, Dhivya Sridaran, Cody Weimholt

|Jun 17, 2023
Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor.

Mithila Sawant, Audrey Wilson, Dhivya Sridaran

|Jun 09, 2023
Histone H2A Lys130 acetylation epigenetically regulates androgen production in prostate cancer.

Thanh Nguyen, Dhivya Sridaran, Surbhi Chouhan

|Nov 14, 2022
Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance.

Dhivya Sridaran, Surbhi Chouhan, Kiran Mahajan

|Oct 17, 2022
The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.

Martin Sjöström, Shuang G Zhao, Samuel Levy

Pageof 2

Frequent Collaborators

5 joint publications

Jingqin Luo

5 joint publications

Felix Y Feng

5 joint publications

Tiandao Li

4 joint publications

Dhivya Sridaran